These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5431329)

  • 41. Hydrotherapeutic action of crude coal tar in selected dermatoses.
    SILVER H; BERESTON ES; SCHAM MJ
    N Y State J Med; 1955 Jun; 55(12):1724-7. PubMed ID: 14383993
    [No Abstract]   [Full Text] [Related]  

  • 42. The nature and molecular basis of cutaneous photosensitivity reactions to psoralens and coal tar.
    Pathak MA; Joshi PC
    J Invest Dermatol; 1983 Jun; 80 Suppl():66s-74s. PubMed ID: 6854058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of psoriasis.
    Bryant BG
    Am J Hosp Pharm; 1980 Jun; 37(6):814-20. PubMed ID: 6994496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psoriasis is not a contraindication for alpha interferon treatment in patients with chronic hepatitis C.
    Rahamimov R; Klaus S; Tur-Kaspa R
    Acta Derm Venereol; 1995 Jan; 75(1):86. PubMed ID: 7747549
    [No Abstract]   [Full Text] [Related]  

  • 45. Topical psoriasis therapy.
    Federman DG; Froelich CW; Kirsner RS
    Am Fam Physician; 1999 Feb; 59(4):957-62, 964. PubMed ID: 10068717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of psoriasis with Goeckerman technic.
    SOLOMON WM; NETHERTON EW; NELSON PA; ZEITER WJ
    Arch Phys Med Rehabil; 1955 Feb; 36(2):74-7. PubMed ID: 13229486
    [No Abstract]   [Full Text] [Related]  

  • 47. Topical treatment of psoriasis with tar.
    Muller SA
    Acta Derm Venereol Suppl (Stockh); 1984; 112():7-10. PubMed ID: 6596827
    [No Abstract]   [Full Text] [Related]  

  • 48. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.
    Andrys C; Borska L; Pohl D; Fiala Z; Hamakova K; Krejsek J
    Arch Dermatol Res; 2007 Mar; 298(10):479-83. PubMed ID: 17221216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [On the importance of the Goekerman treatment in psoriasis. (Preliminary note)].
    Témime P; Oddoze L; Marchand JP
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(5):607-9. PubMed ID: 5587898
    [No Abstract]   [Full Text] [Related]  

  • 50. [Epidermal homeostasis and the problem of psoriasis].
    Khaliavkin AV
    Izv Akad Nauk SSSR Biol; 1982; (1):156-9. PubMed ID: 7037905
    [No Abstract]   [Full Text] [Related]  

  • 51. The benefits of switching to nurse-led management of patients with psoriasis.
    Riddoch C
    Prof Nurse; 2005 Jan; 20(5):38-40. PubMed ID: 15682996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Acceleration of the ultra-violet provoked lipid peroxidation of human surface fat by means of anti-psoriatic substances].
    Meffert H; Waldmann U
    Dermatol Monatsschr; 1970 Aug; 156(8):771-5. PubMed ID: 5476351
    [No Abstract]   [Full Text] [Related]  

  • 53. Generalized pustular psoriasis.
    Ogawa M; Baughman RD; Clendenning WE
    Arch Dermatol; 1969 Jun; 99(6):671-3. PubMed ID: 5795746
    [No Abstract]   [Full Text] [Related]  

  • 54. A betamethasone-calcipotriene combination for psoriasis.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):55-6. PubMed ID: 16841023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psoriasis.
    Davies A
    Nurs Mirror; 1983 Jul; 157(4):19-21. PubMed ID: 6554749
    [No Abstract]   [Full Text] [Related]  

  • 56. [Critical evaluation of the problem of psoriasis].
    Novotný F
    Cesk Dermatol; 1969 Sep; 44(4):129-40. PubMed ID: 5406578
    [No Abstract]   [Full Text] [Related]  

  • 57. Fluocortolone.
    Freshwater DG
    Br J Dermatol; 1967 Dec; 79(12):729. PubMed ID: 6064946
    [No Abstract]   [Full Text] [Related]  

  • 58. [What's new in psoriasis? IV international symposium in Stanford, 6-11 July 1986].
    Jabłońska S; Majewski S; Gliński W; Wolska H
    Przegl Dermatol; 1987; 74(2):100-11. PubMed ID: 3313529
    [No Abstract]   [Full Text] [Related]  

  • 59. Activation pathways in psoriasis.
    Farber EM; Fraki JE
    Cutis; 1984 Dec; 34(6):535. PubMed ID: 6518816
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pathogenesis and treatment of psoriasis].
    Igoshin IuM
    Vestn Dermatol Venerol; 1977 Jun; (6):13-5. PubMed ID: 883398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.